Etomidate is a short-acting, intravenous anesthetic agent that has been used for induction of anesthesia since the early 1970s. Etomidate has a rapid onset and is relatively well tolerated. The most common side effects are transient hypotension, myoclonic jerks, and muscle fasciculation. Etomidate also has a low incidence of nausea and vomiting postoperatively. Because of its properties, etomidate is often used for induction of anesthesia during rapid sequence intubation or in emergency surgical settings. It is also useful for short or urgent procedures where rapid anesthetic onset is desired. Common side effect reported is pain at the injection site. Etomidate has been shown to be an effective anesthetic in children and adults, with a good safety record.
Etomidate is a short-acting, intravenous anesthetic agent tat has been used in critically ill and injured patients. The therapeutic range for etomidate is 0.2-0.4 mcg/mL.
References: Drug Bank. Etomidate. (2020). Retrieved from hat has a rapid onset and offset. It is often used for induction of anesthesia prior to surgery or other procedures. The therapeutic range for etomidate is 0.3-0.4 mg/kg. This means that the desired effect of etomidate will be achieved at a dose of 0.3-0.4 mg/kg. Etomidate has a wide margin of safety, which means that it is unlikely to cause serious side effects at doses within the therapeutic range.
Etomidate is a sedative that works by depressing the brain's activity. This leads to a decrease in consciousness and a feeling of relaxation. Etomidate is typically used for procedures that do not require anesthesia, suh as minor surgeries, diagnostic tests and procedures. It works by acting on the receptors in the brain that control arousal and alertness. This causes a decrease in consciousness, allowing to perform their procedure without pain or discomfort. Such as imaging studies or minor surgeries. It can also be used as an induction agent for more invasive procedures, such as major surgeries or endoscopic procedures. such as general anesthesia. The dose of etomidate needed for sedation depends on the individual's weight, age, health status, and response to the medication.
The side effects of etomidate are typically short-lived and mild, but can include: Dizziness, Nausea or vomiting, Headache, Anxiety or agitation, Tremors or muscle twitching, Increased heart rate, High blood pressure
When administering etomidate, it is important to know the proper dose. The dose for etomidate is 0.3 mg/kg, which should be given slowly over a period of 30-60 seconds. It is also important to monitor the patient’s vital signs and response to the drug. If there is no response after one minute, a second dose of 0.2 mg/kg may be given. Make sure to keep track of the time between doses, as etomidate can cause respiratory depression if given too close together. It is also important to have an emergency cart with resuscitation equipment nearby in case of a reaction or adverse event remember that etomidate should only be given to patients who are hemodynamically stable.
All in all, etomidate is a safe and effective general anesthetic. It is important to understand the recommended dose before administering it as this could have serious implications for your patient's safety and wellbeing. It is also important to monitor for side effects and be prepared to respond appropriately if any occur. Etomidate is a useful tool for many medical procedures, but it must be used responsibly in order to ensure that your patient has the best possible outcome health. As with any other drug administration, make sure you are aware of the potential side effects associated with etomidate so that you can provide the best care possible for your patients. With these points in mind, we hope that you now feel better equipped to administer etomidate effectively and safely.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation